Indications
for cisplatin beads include tumors removed with «thin margins» such as:
These immune system — boosting agents are the first - ever FDA - approved treatments
for cisplatin - ineligible bladder cancer.
All patients enrolled in the study were ineligible
for cisplatin because of medical frailty.
Not exact matches
A team of researchers led by Dr. Jian Zuo screened over 4,000 drugs
for their ability to protect cochlear cells from the chemotherapy agent
cisplatin.
«We found that pemetrexed combined with
cisplatin is less toxic, well tolerated, and should be developed
for further treatment of cervical cancer,» said gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer Center.
They used this method first in 2015 to generate a UV repair map of the human genome, and in 2016 they used the XR - seq method to generate the damage and repair maps of the anticancer
cisplatin drug
for the entire human genome.
Cisplatin - based chemoradiation is the standard therapy
for locally advanced cervical cancer.
They found that adaptive immunity is reversely associated with resistance of
cisplatin, the drug used
for ovarian cancer.
A Phase 3 Study of Active Surveillance
for Low Risk and a Randomized Trial of Carboplatin vs.
Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Cisplatin - based concurrent chemoradiotherapy has become the standard treatment
for locally advanced non-small cell lung cancer (NSCLC).
The aerosol administration was time consuming needing in total ten minutes
for nebulisation of 2mls of
cisplatin.
The structure of these transporters is essential to the rational design of agents which control their function.30 - 32 In our current work we investigated the chemotherapy agent
cisplatin since it the most used chemotherapy drug
for a number of cancer types and the application would have an impact on several cancers.
8/27/2008 Variation of Normal Protein Could Be Key to Resistance to Common Cancer Drug Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug,
cisplatin, may not always work
for every cancer patient.
The researchers are now testing new ways to decrease these side effects, including substituting paclitaxel (Taxol), which causes fewer side effects,
for the highly toxic
cisplatin.
This drug is indicated in combination with
Cisplatin (a chemotherapeutic drug)
for the first - line treatment of patients with inoperable, locally advanced, or metastatic non-small cell lung cancer.
FDA on chemo beads
Cisplatin beads have not been approved by the Food and Drug Administration (FDA)
for use in cats.
Dogs that were only treated with chemotherapy (
Cisplatin) survived
for a median of 202 days.
Cancer surgery
Cisplatin beads (tiny local chemo pearls that dissolve) Feline fibrosarcoma * Jaw surgery (Mandibulectomy / Maxillectomy) Jaw surgery (Mandibulectomy / Maxillectomy) Limb sparing
for cancer (osteosarcoma) Mastectomy (mammary tumors) * Nasal tumors (rhinotomy, rhinoplasty) Tumors in multiple other locations (mentioned above and below) *
Evaluation of
cisplatin combined with piroxicam
for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
The treatment results are almost identical
for the 3 drugs; because
cisplatin has to be given as an IV infusion, most oncologists are no longer using it.
The chemotherapeutic agents typically used
for Greyhounds with OSA are
cisplatin, carboplatin, or doxorubin.
Cisplatin and doxorubicin combination chemotherapy
for the treatment of canine osteosarcoma: a pilot study.